Search result for 'pulmonary arterial hypertension'

Alembic Pharmaceuticals receives tentative USFDA approval for its generic Selexipag injection, a treatment for pulmonary arterial hypertension. The company may be eligible for 180 days of generic...

Lupin receives USFDA approval to market generic Selexipag for injection, a treatment for pulmonary arterial hypertension. The drug will be manufactured at the company's Nagpur facility.